Diabetes And Oncology Drive Interest in China - Shanghai R&D Summit

SHANGHAI - Pharma companies and investors are focusing their interest in China, as they are elsewhere, on diabetes and oncology, but they face unique challenges, according to panelists at a recent R&D conference in Shanghai